Back to Search Start Over

Fine Particulate Matter Air Pollution and Mortality among Pediatric, Adolescent, and Young Adult Cancer Patients.

Authors :
Ou JY
Hanson HA
Ramsay JM
Kaddas HK
Pope CA 3rd
Leiser CL
VanDerslice J
Kirchhoff AC
Source :
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2020 Oct; Vol. 29 (10), pp. 1929-1939. Date of Electronic Publication: 2020 May 13.
Publication Year :
2020

Abstract

Background: Air pollution is a carcinogen and causes pulmonary and cardiac complications. We examined the association of fine particulate matter pollution (PM <subscript>2.5</subscript> ) and mortality from cancer and all causes among pediatric, adolescent, and young adult (AYA) patients with cancer in Utah, a state with considerable variation in PM <subscript>2.5</subscript> .<br />Methods: We followed 2,444 pediatric (diagnosed ages 0-14) and 13,459 AYA (diagnosed ages 15-39) patients diagnosed in 1986-2015 from diagnosis to 5 and 10 years postdiagnosis, death, or emigration. We measured average monthly PM <subscript>2.5</subscript> by ZIP code during follow-up. Separate pediatric and AYA multivariable Cox models estimated the association of PM <subscript>2.5</subscript> and mortality. Among AYAs, we examined effect modification of PM <subscript>2.5</subscript> and mortality by stage while controlling for cancer type.<br />Results: Increases in PM <subscript>2.5</subscript> per 5 μg/m <superscript>3</superscript> were associated with cancer mortality in pediatric lymphomas and central nervous system (CNS) tumors at both time points, and all cause mortality in lymphoid leukemias [HR <subscript>5-year</subscript> = 1.32 (1.02-1.71)]. Among AYAs, PM <subscript>2.5</subscript> per 5 μg/m <superscript>3</superscript> was associated with cancer mortality in CNS tumors and carcinomas at both time points, and all cause mortality for all AYA cancer types [HR <subscript>5-year</subscript> = 1.06 (1.01-1.13)]. PM <subscript>2.5</subscript> ≥12 μg/m <superscript>3</superscript> was associated with cancer mortality among breast [HR <subscript>5-year</subscript> = 1.50 (1.29-1.74); HR <subscript>10-year</subscript> = 1.30 (1.13-1.50)] and colorectal cancers [HR <subscript>5-year</subscript> = 1.74 (1.29-2.35); HR <subscript>10-year</subscript> = 1.67 (1.20-2.31)] at both time points. Effect modification by stage was significant, with local tumors at highest risk.<br />Conclusions: PM <subscript>2.5</subscript> was associated with mortality in pediatric and AYA patients with specific cancers.<br />Impact: Limiting PM <subscript>2.5</subscript> exposure may be important for young cancer patients with certain cancers. See all articles in this CEBP Focus section, "Environmental Carcinogenesis: Pathways to Prevention."<br /> (©2020 American Association for Cancer Research.)

Details

Language :
English
ISSN :
1538-7755
Volume :
29
Issue :
10
Database :
MEDLINE
Journal :
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Publication Type :
Academic Journal
Accession number :
32404444
Full Text :
https://doi.org/10.1158/1055-9965.EPI-19-1363